NeuroNEXT: accelerating drug development in neurology

Lancet Neurol. 2012 Feb;11(2):119. doi: 10.1016/S1474-4422(12)70008-X.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers*
  • Clinical Trials, Phase II as Topic*
  • Humans
  • Multicenter Studies as Topic*
  • National Institute of Neurological Disorders and Stroke (U.S.)*
  • Nervous System Diseases / diagnosis
  • Nervous System Diseases / drug therapy*
  • United States


  • Biomarkers